# Primary UVB-311nm and Adalimumab in Psoriasis Patients

> **NCT00638261** · NA · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 4 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **RADIATION:** UVB-311nm

## Key facts

- **NCT ID:** NCT00638261
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2012-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00638261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00638261, "Primary UVB-311nm and Adalimumab in Psoriasis Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00638261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*